Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors.
Stickdorn J, Stein L, Arnold-Schild D, Hahlbrock J, Medina-Montano C, Bartneck J, Ziß T, Montermann E, Kappel C, Hobernik D, Haist M, Yurugi H, Raabe M, Best A, Rajalingam K, Radsak MP, David SA, Koynov K, Bros M, Grabbe S, Schild H, Nuhn L.
Stickdorn J, et al. Among authors: nuhn l.
ACS Nano. 2022 Mar 22;16(3):4426-4443. doi: 10.1021/acsnano.1c10709. Epub 2022 Feb 1.
ACS Nano. 2022.
PMID: 35103463
Free PMC article.